It was recently shown that metformin blocks NLRP3 inflammasome activation including inhibition of IL-1β and IL-6 in alveolar macrophages attenuating SARS-CoV-2-induced ARDS in a mouse model.93 Here, NLRP3 is linked to acute respiratory distress syndrome.